Clinical Trial Update: Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the pharmacokinetic and pharmacodynamic properties of rapid-acting insulin analogs in individuals with Type 1 diabetes mellitus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Rapid-acting insulin analogs (insulin analog)

Snippet

Sponsor: Yale University | Conditions: Diabetes Mellitus, Type I | Phase 1 | Status: COMPLETED